| Code | CSB-RA007681MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody disclosed in US2020317814, targeting ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3). ENPP3 is a cell surface enzyme that hydrolyzes phosphodiester bonds in various nucleotides and exhibits particularly high expression in renal proximal tubular cells and certain epithelial tissues. This protein plays important roles in purinergic signaling and nucleotide metabolism. ENPP3 has emerged as a significant biomarker and therapeutic target in oncology, with overexpression documented in renal cell carcinoma, bladder cancer, and other malignancies where it contributes to tumor progression and metastasis.
The reference antibody described in US2020317814 was designed for specific recognition of ENPP3-expressing cells, making this biosimilar valuable for cancer research applications. This antibody enables investigators to study ENPP3 expression patterns, evaluate its role in tumor biology, and explore targeted therapeutic strategies. The reagent supports research into ENPP3-mediated signaling pathways and its potential as a diagnostic or prognostic marker in various cancers.
There are currently no reviews for this product.